<i>R</i> -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential

Authors

Pierre Llorach (ORCID: https://orcid.org/0000-0002-4457-7800)
Arabo A. Avanes (ORCID: https://orcid.org/0000-0001-6211-7966)
Cassandra J. Hatzipantelis (ORCID: https://orcid.org/0000-0001-5376-7887)
Juliana S. Salgado (ORCID: https://orcid.org/0000-0002-3687-846X)
Maxemiliano V. Vargas (ORCID: https://orcid.org/0000-0002-3637-1896)
David E. Olson (ORCID: https://orcid.org/0000-0002-4517-0543)
Lee E. Dunlap (ORCID: https://orcid.org/0000-0002-9365-8025)
Robert J. Tombari (ORCID: https://orcid.org/0000-0002-6561-8181)
Boris D. Heifets (ORCID: https://orcid.org/0000-0003-1474-0379)
Sam Vaillancourt

Institutions

Multidisciplinary Association for Psychedelic Studies (US)
Center for Neurosciences (US)
Division of Undergraduate Education (US)
Institute of Molecular Medicine (IN)
Cellular Research (United States) (US)
Institut de Biologie Moléculaire et Cellulaire (FR)
University of California, Davis (US)
Stanford University (US)

Publication Details

Journal: ACS Chemical Neuroscience
Published: 2026-04-21
DOI: https://doi.org/10.1021/acschemneuro.5c00891
Primary Topic: Psychedelics and Drug Studies
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Camille and Henry Dreyfus Foundation
Pershing Square Foundation
University of California, Davis

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential

Pierre Llorach, Arabo A. Avanes, Cassandra J. Hatzipantelis, Juliana S. Salgado et al.

Apr 21, 2026

ACS Chemical Neuroscience

Psychedelics and Drug Studies

article

R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential

Pierre Llorach, Arabo A. Avanes, Cassandra J. Hatzipantelis, Juliana S. Salgado, Maxemiliano V. Vargas, David E. Olson, Lee E. Dunlap, Robert J. Tombari, Boris D. Heifets, Sam Vaillancourt

April 21, 2026article en

Abstract

No abstract available for this paper.

ACS Chemical NeuroscienceVol. 17(9)

Multidisciplinary Association for Psychedelic Studies (US), Center for Neurosciences (US), Division of Undergraduate Education (US), Institute of Molecular Medicine (IN), Cellular Research (United States) (US), Institut de Biologie Moléculaire et Cellulaire (FR), University of California, Davis (US), Stanford University (US)

Camille and Henry Dreyfus Foundation, Pershing Square Foundation, University of California, Davis

Good health and well-being

Openalex Percentile: Top 17%

Psychedelics and Drug Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<i>R</i> -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential — Pierre Llorach, Arabo A. Avanes, et al. · ACS Chemical Neuroscience (2026) | TGRS Research Map | TGRS